Azathioprine hypersensitivity syndrome: report of two cases
- PMID: 34011657
- PMCID: PMC8137243
- DOI: 10.1136/bcr-2020-239099
Azathioprine hypersensitivity syndrome: report of two cases
Abstract
Azathioprine hypersensitivity syndrome is a rare but potentially severe side effect of azathioprine use. It has a variable and non-specific presentation making it difficult to distinguish from sepsis or disease relapse. High clinical suspicion is therefore required for recognition and prompt cessation of azathioprine for symptom resolution. Herewith two cases of severe azathioprine hypersensitivity syndrome are described, one in association with Sweet syndrome. Both presented with vague symptoms 2 weeks after commencing azathioprine for antineutrophil cytoplasmic antibody vasculitis. The differentials of sepsis and disease relapse were considered prior to cessation of azathioprine which resulted in a dramatic improvement in both cases. These cases highlight the diagnostic challenge azathioprine hypersensitivity syndrome presents. It should be suspected when there is a temporal relationship to drug initiation, with absence of infection or serological evidence of disease relapse.
Keywords: renal system; unwanted effects / adverse reactions.
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
-
- Sweet Syndrome - NORD (National Organization for Rare Disorders), 2019. Available: https://rarediseases.org/rare-diseases/sweet-syndrome/
-
- Acute febrile neutrophilic dermatosis | DermNet NZ, 2019. Available: https://www.dermnetnz.org/topics/acute-febrile-neutrophilic-dermatosis/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical